Dr. Reddy's Executive and Leadership Team

Erez Israeli, the Chief Executive Officer at Dr. Reddy's, directs the overarching corporate strategy and global pharmaceutical operations. Overseeing the expansion of the product portfolio, the Chief Executive Officer ensures alignment between research initiatives and market demands across international territories. This leadership role involves managing complex supply chains and fostering partnerships to maintain a competitive edge in the multinational pharmaceutical sector. By prioritizing innovation and affordability, Erez Israeli directly impacts the company's ability to provide accessible healthcare solutions to diverse populations. Ultimately, the Chief Executive Officer secures long-term growth by navigating regulatory landscapes and optimizing operational efficiency across all business units, ensuring that the organization remains a leader in the global pharmaceutical industry while consistently meeting the evolving needs of patients worldwide.

Sandeep Khandelwal, the Chief Executive Officer, CISUR (Asia, Africa, Australia) at Dr. Reddy's, directs the commercial strategy and market expansion across the diverse regions of Asia, Africa, and Australia. Overseeing the distribution of pharmaceutical products in these emerging and established markets, the Chief Executive Officer, CISUR (Asia, Africa, Australia) ensures that the company addresses the unique healthcare needs of these populations. This leadership role involves building strategic alliances with local distributors and navigating complex regional regulatory environments. By tailoring the product portfolio to meet local demand, Sandeep Khandelwal drives significant growth and increases the accessibility of affordable medicines. The Chief Executive Officer, CISUR (Asia, Africa, Australia) manages regional teams to ensure operational alignment with the global corporate mission. Through proactive market engagement and strategic planning, the Chief Executive Officer, CISUR (Asia, Africa, Australia) strengthens the company's footprint in these critical international territories.

M. Narasimham, the Chief Financial Officer at Dr. Reddy's, manages the global financial health and capital allocation strategies of the organization. Overseeing fiscal planning and investor relations, the Chief Financial Officer ensures that the company maintains a robust balance sheet to support ongoing pharmaceutical research and development. This leadership role involves monitoring global market trends and mitigating financial risks associated with international operations. By optimizing cost structures and driving capital efficiency, M. Narasimham supports the long-term sustainability of the business model. The Chief Financial Officer collaborates with the executive team to evaluate investment opportunities in new drug pipelines and manufacturing technologies. Through rigorous financial oversight and strategic budgeting, the Chief Financial Officer provides the necessary resources to advance the company's mission of delivering innovative and affordable healthcare solutions to patients across the globe.

Stephen Peterson, the Chief Financial Officer (North America) at Dr. Reddy's, directs the financial operations and strategic planning for the North American market. Overseeing regional budgeting and revenue management, the Chief Financial Officer (North America) ensures that the company's financial performance aligns with the specific demands of the highly competitive pharmaceutical landscape in this region. This leadership role involves managing complex pricing strategies and navigating the unique regulatory requirements of the North American healthcare system. By analyzing regional market data and optimizing operational expenditures, Stephen Peterson drives profitability and supports the expansion of the product portfolio. The Chief Financial Officer (North America) works closely with regional leadership to ensure that financial resources are effectively deployed to capture market share. Through disciplined fiscal management, the Chief Financial Officer (North America) strengthens the company's position as a key provider of affordable medicines.

Neelima Kulkarni, the Head Chief Technology Officer, Site Human Resources 2 at Dr. Reddy's, architects the technological infrastructure and human capital strategies for specific manufacturing sites. Overseeing the integration of advanced digital systems into pharmaceutical production, the Head Chief Technology Officer, Site Human Resources 2 ensures that operational workflows remain efficient and compliant with global quality standards. This leadership role involves managing site-specific talent development and fostering a culture of innovation within the technical teams. By aligning human resources initiatives with technological upgrades, Neelima Kulkarni drives productivity and enhances the overall manufacturing capabilities of the organization. The Head Chief Technology Officer, Site Human Resources 2 collaborates with cross-functional teams to implement cutting-edge solutions that support the company's mission of delivering high-quality medicines. Through strategic oversight of both technology and personnel, the Head Chief Technology Officer, Site Human Resources 2 ensures operational excellence.

Maneesh Ramanadham, the Director & Chief of Staff at Dr. Reddy's, coordinates the strategic initiatives and operational workflows of the executive office. Overseeing the implementation of corporate priorities, the Director & Chief of Staff ensures that the leadership team remains focused on the core mission of delivering innovative pharmaceutical solutions. This leadership role involves facilitating communication between various departments and the C-suite to streamline decision-making processes. By managing high-priority projects and monitoring organizational performance, Maneesh Ramanadham supports the effective execution of the company's long-term strategy. The Director & Chief of Staff acts as a central point of contact for cross-functional collaboration, ensuring that all business units are aligned with the overarching goals of the organization. Through meticulous planning and coordination, the Director & Chief of Staff enhances the efficiency of the executive leadership team and contributes to the overall success of the company.

Ks Toshniwal, the Vice President & Head of Manufacturing & Chief Technology Officer, Hyd & Mlg at Dr. Reddy's, directs the manufacturing operations and technological advancements at the Hyderabad and Miryalaguda facilities. Overseeing the production of pharmaceutical compounds, the Vice President & Head of Manufacturing & Chief Technology Officer, Hyd & Mlg ensures that all processes adhere to stringent quality and safety standards. This leadership role involves implementing state-of-the-art manufacturing technologies to increase output and reduce production costs. By optimizing the supply chain and enhancing technical capabilities, Ks Toshniwal supports the company's ability to provide affordable medicines to global markets. The Vice President & Head of Manufacturing & Chief Technology Officer, Hyd & Mlg collaborates with engineering teams to drive continuous improvement and innovation in drug manufacturing. Through operational excellence and technical leadership, the Vice President & Head of Manufacturing & Chief Technology Officer, Hyd & Mlg ensures the reliability of the supply chain.

Rajdeep Das, the Global Manufacturing & Operations Chief of Staff at Dr. Reddy's, manages the operational integration and strategic alignment of the company's global manufacturing network. Overseeing the coordination between international production sites, the Global Manufacturing & Operations Chief of Staff ensures that operational processes are standardized and efficient across all regions. This leadership role involves monitoring global production metrics and identifying opportunities for process optimization to support the company's mission of delivering affordable healthcare. By facilitating communication between manufacturing heads and the executive team, Rajdeep Das drives the implementation of global operational strategies. The Global Manufacturing & Operations Chief of Staff supports the scaling of production capabilities to meet the growing demand for pharmaceutical products. Through rigorous oversight and strategic coordination, the Global Manufacturing & Operations Chief of Staff ensures that the company's manufacturing operations remain agile, compliant, and highly productive on a global scale.

Kamala Bhavaraju, the Head- Clinical Bioanalytics and Chief of Staff at Dr. Reddy's, directs the clinical bioanalytics division and manages strategic administrative functions for the research organization. Overseeing the analysis of clinical data, the Head- Clinical Bioanalytics and Chief of Staff ensures that the company's drug development programs are supported by rigorous scientific evidence and regulatory compliance. This leadership role involves coordinating with research teams to validate the efficacy and safety of new pharmaceutical products. By integrating bioanalytical insights into the development pipeline, Kamala Bhavaraju accelerates the delivery of innovative medicines to the market. The Head- Clinical Bioanalytics and Chief of Staff also manages the administrative operations of the research division, ensuring that resources are effectively allocated to high-impact projects. Through scientific expertise and strategic management, the Head- Clinical Bioanalytics and Chief of Staff contributes to the company's mission of improving patient lives through evidence-based pharmaceutical innovation.

Sheri Chesebrough, the Head of Country at Dr. Reddy's, manages regional market penetration and local pharmaceutical distribution strategies. Overseeing the execution of commercial objectives, the Head of Country ensures that the company's therapeutic offerings reach target demographics effectively. This leadership role involves coordinating with local regulatory bodies and healthcare providers to expand the footprint of the organization within specific geographic markets. By analyzing regional consumption patterns and competitive dynamics, Sheri Chesebrough drives revenue growth and strengthens brand presence. The Head of Country maintains operational excellence by aligning local sales teams with the broader corporate mission of providing affordable medicines. Through strategic resource allocation and market-specific engagement, the Head of Country fosters sustainable growth and enhances the overall impact of the pharmaceutical portfolio within the assigned region.